SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-10-005502
Filing Date
2010-11-08
Accepted
2010-11-08 17:24:13
Documents
11
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 c63214_10q.htm 10-Q 818570
2 c63214_ex31-1.htm EX-31.1 10267
3 c63214_ex31-2.htm EX-31.2 10434
4 c63214_ex32-1.htm EX-32.1 3199
5 c63214_ex32-2.htm EX-32.2 3415
  Complete submission text file 0000930413-10-005502.txt   3697997

Data Files

Seq Description Document Type Size
6 svnt-20100930.xml EX-101.INS 638313
7 svnt-20100930.xsd EX-101.SCH 24270
8 svnt-20100930_cal.xml EX-101.CAL 15296
9 svnt-20100930_def.xml EX-101.DEF 19686
10 svnt-20100930_lab.xml EX-101.LAB 137363
11 svnt-20100930_pre.xml EX-101.PRE 87294
Mailing Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816
Business Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816 7324189300
SAVIENT PHARMACEUTICALS INC (Filer) CIK: 0000722104 (see all company filings)

IRS No.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15313 | Film No.: 101173404
SIC: 2833 Medicinal Chemicals & Botanical Products